New Oral Anticoagulants vs Warfarin in Kidney Transplant.

被引:0
|
作者
Raslan, S. R. [1 ]
Alkortas, D. [2 ]
机构
[1] King Faisal Specialist & Hosp Res Ctr, Pharmaceut Care, Riyadh, Saudi Arabia
[2] KFSH & RC, Riyadh, Saudi Arabia
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
442
引用
收藏
页码:526 / 526
页数:1
相关论文
共 50 条
  • [1] Safety and Mortality Benefit of Direct Oral Anticoagulants in Kidney Transplant.
    Firth, C.
    Apolinario, M.
    Shamoun, F.
    Lim, E.
    Zhang, N.
    Keddis, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1070 - 1070
  • [4] New Oral Anticoagulants vs. Warfarin Treatment: No Need for Pharmacogenomics?
    Baker, W. L.
    Chamberlin, K. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (01) : 17 - 19
  • [5] New oral anticoagulants: an alternative to warfarin
    Wilkinson, Peter
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (09) : 498 - 501
  • [6] New oral anticoagulants: will they replace warfarin?
    Little, James W.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2012, 113 (05): : 575 - 580
  • [7] Assessment of a New Method of Warfarin Management vs the New Oral Anticoagulants and Conventional Warfarin Management in Atrial Fibrillation
    Bussey, Henry I.
    Nutescu, Edith
    STROKE, 2015, 46
  • [8] New oral anticoagulants (NOACs) vs. warfarin: Are doctors ready to switch?
    Ahmed, Mahin
    Gautam, Manish
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [9] Monitoring of mortality associated to new oral anticoagulants vs warfarin in atrial fibrillation
    Mayer, Flavia
    Kirchmayer, Ursula
    Agabiti, Nera
    Cappai, Giovanna
    Fusco, Danilo
    Davoli, Marina
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 169 - 169
  • [10] Safety and Efficacy of Direct-Acting Oral Anticoagulants versus Warfarin in Kidney Transplant Recipients
    Bixby, A. L.
    Shaikh, S. A.
    Naik, A. S.
    Cotiguala, L.
    McMurry, K.
    Samaniego-Picota, M. D.
    Marshall, V. D.
    Park, J. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1004 - 1005